Acacia Pharma

News

Acacia Pharma is to raise new funds through an initial global offering and launch on to the Euronext Brussels stock exchange

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.